Detalhe da pesquisa
1.
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.
Hepatobiliary Pancreat Dis Int
; 21(1): 10-24, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538570
2.
Advances in novel molecular typing and precise treatment strategies for small cell lung cancer.
Chin J Cancer Res
; 33(4): 522-534, 2021 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584377
3.
Challenges of evaluating immunotherapy efficacy in solid tumors.
Chin J Cancer Res
; 31(6): 853-861, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31949388
4.
Regulation of fatty acid synthase on tumor and progress in the development of related therapies.
Chin Med J (Engl)
; 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273440
5.
Mitochondrial immune regulation and anti-tumor immunotherapy strategies targeting mitochondria.
Cancer Lett
; 564: 216223, 2023 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172686
6.
Precision targeted therapy for EGFR mutation-positive NSCLC: Dilemmas and coping strategies.
Thorac Cancer
; 14(13): 1121-1134, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37005552
7.
Therapeutic strategies targeting metabolic characteristics of cancer cells.
Crit Rev Oncol Hematol
; 187: 104037, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236409
8.
Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies.
Chin Med J (Engl)
; 136(23): 2776-2786, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369640
9.
Burgeoning Exploration of the Role of Natural Killer Cells in Anti-PD-1/PD-L1 Therapy.
Front Immunol
; 13: 886931, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634343
10.
Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing.
Front Immunol
; 13: 890166, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833121
11.
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives.
Cancer Biol Med
; 19(12)2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245210
12.
Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns.
J Cancer Res Clin Oncol
; 148(1): 163-176, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34698913
13.
Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC.
Thorac Cancer
; 13(19): 2799-2807, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35975338
14.
A brand new era of cancer immunotherapy: breakthroughs and challenges.
Chin Med J (Engl)
; 134(11): 1267-1275, 2021 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039862
15.
Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events.
Cancer Biol Med
; 2021 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34259422
16.
Cost-effectiveness of icotinib versus whole-brain irradiation with or without chemotherapy in EGFR-mutant NSCLC patients with brain metastases.
Asia Pac J Clin Oncol
; 17(2): e40-e47, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31957251
17.
Correlation of Peripheral Blood Parameters and Immune-Related Adverse Events with the Efficacy of Immune Checkpoint Inhibitors.
J Oncol
; 2021: 9935076, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34335763
18.
Single Nucleotide Polymorphisms in HOTAIR Are Related to Breast Cancer Risk and Prognosis in the Northeastern Chinese Population.
Front Oncol
; 11: 706428, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322392
19.
Correlation of circulating tumor DNA EGFR mutation levels with clinical outcomes in patients with advanced lung adenocarcinoma.
Chin Med J (Engl)
; 134(20): 2430-2437, 2021 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669636
20.
The Chinese Thoracic Oncology Group (CTONG) therapeutic option scoring system: a multiple-parameter framework to assess the value of lung cancer treatment options.
Transl Lung Cancer Res
; 10(8): 3594-3607, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34584859